Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP

NCT00144534 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: MRA (Tocilizumab)

Sponsor

Chugai Pharmaceutical